Assessing the tolerability of alternative prenatal multivitamins
Are you interested in participating in a study?
A Motherisk study on PregVit®: assessing the tolerability of alternative prenatal multivitamins
Currently, the Motherisk program at the Hospital for Sick Children (Toronto, Canada) is conducting a study to assess the tolerability of 2 alternative prenatal multivitamins, other than Materna® or similar multivitamins. The study is still enrolling pregnant women who are interested in trying a potentially more tolerable prenatal multivitamin.
Who can participate in the study?
Any pregnant woman who either did not start or discontinued her multivitamins (prenatal or regular) due to nausea and vomiting of pregnancy (NVP), gastrointestinal symptoms (i.e. nausea, vomiting, constipation, diarrhea, heartburn), gastrointestinal medical conditions (i.e. Irritable bowel syndrome, Crohn's disease, ulcerative colitis, peptic/duodenal ulcer, etc.), or difficulties with the supplement itself (i.e. large tablet size, bitter taste, chalky texture), or taking folic acid alone.
What are the alternative prenatal multivitamins?
Women are randomly assigned to try either PregVit® or Orifer F®. These are 2 prenatal multivitamins that differ from each other, but they are also potentially more tolerable compared to another prenatal multivitamin Materna®.
What is involved in participating in the study?
To join the study or obtain more information:
Patricia Nguyen, study coordinator
Telephone: 416-813-7283 (voicemail #2)
Email: patricia.nguyen@utoronto.ca
ATTN: Physicians, obstetricians, midwives, or other healthcare providers.
If you have a patient who is interested in participating in the study, please contact the study coordinator and leave the patient's name and telephone number. The study coordinator will contact the patient.
|
|
